ATA42190A - Gelatinekapseln mit einem gehalt an ranitidin (salz) - Google Patents

Gelatinekapseln mit einem gehalt an ranitidin (salz)

Info

Publication number: ATA42190A
Authority: AT; Austria
Prior art keywords: salt; capsules containing; gelatine capsules; containing ranitidine; ranitidine
Prior art date: 1989-02-23

Application number

AT0042190A

Other languages

English (en)

Other versions

AT401727B (de

Original Assignee

Glaxo Canada

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-23

Filing date

1990-02-22

Publication date

1996-04-15

1990-02-22 Application filed by Glaxo Canada filed Critical Glaxo Canada

1996-04-15 Publication of ATA42190A publication Critical patent/ATA42190A/de

1996-11-25 Application granted granted Critical

1996-11-25 Publication of AT401727B publication Critical patent/AT401727B/de

Links

239000001828 Gelatine Substances 0.000 title 1
239000002775 capsule Substances 0.000 title 1
229920000159 gelatin Polymers 0.000 title 1
235000019322 gelatine Nutrition 0.000 title 1
VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 title 1
229960000620 ranitidine Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT0042190A 1989-02-23 1990-02-22 Gelatinekapseln mit einem gehalt an ranitidin (salz) AT401727B (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898904182A GB8904182D0 (en)	1989-02-23	1989-02-23	Pharmaceutical compositions

Publications (2)

Publication Number	Publication Date
ATA42190A true ATA42190A (de)	1996-04-15
AT401727B AT401727B (de)	1996-11-25

Family

ID=10652220

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT0042190A AT401727B (de)	1989-02-23	1990-02-22	Gelatinekapseln mit einem gehalt an ranitidin (salz)

Country Status (26)

Country	Link
US (1)	US5028432A (de)
JP (1)	JP2856817B2 (de)
KR (1)	KR940006271B1 (de)
AT (1)	AT401727B (de)
AU (1)	AU629303B2 (de)
BE (1)	BE1003123A3 (de)
CA (1)	CA2010692C (de)
CH (1)	CH680567A5 (de)
CY (1)	CY1734A (de)
DE (1)	DE4005650C2 (de)
DK (1)	DK170209B1 (de)
FR (1)	FR2643263B1 (de)
GB (2)	GB8904182D0 (de)
HK (1)	HK89493A (de)
HU (1)	HU211930A9 (de)
IE (1)	IE63179B1 (de)
IL (1)	IL93490A (de)
IT (1)	IT1240768B (de)
LU (1)	LU87681A1 (de)
NL (1)	NL193267C (de)
NZ (1)	NZ232642A (de)
PH (1)	PH26972A (de)
SA (1)	SA90100287B1 (de)
SE (1)	SE512412C2 (de)
ZA (1)	ZA901348B (de)
ZW (1)	ZW1790A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU8546591A (en) *	1990-09-13	1992-04-15	Smithkline Beecham Corporation	Non-aqueous liquid oral suspensions
US5571533A (en) *	1992-02-07	1996-11-05	Recordati, S.A., Chemical And Pharmaceutical Company	Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
MX9306393A (es) *	1992-10-16	1994-04-29	Glaxo Group Ltd	Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen.
US5433951A (en) *	1993-10-13	1995-07-18	Bristol-Myers Squibb Company	Sustained release formulation containing captopril and method
DE4341310A1 (de) *	1993-12-03	1995-06-08	Hexal Pharma Gmbh	Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en)	1993-12-13	1994-02-16	Cortecs Ltd	Pharmaceutical formulations
US5407687A (en) *	1994-02-22	1995-04-18	Glaxo Inc.	Ranitidine solid dosage form
GB9405304D0 (en) *	1994-03-16	1994-04-27	Scherer Ltd R P	Delivery systems for hydrophobic drugs
US5538737A (en) *	1994-11-30	1996-07-23	Applied Analytical Industries, Inc.	Oral compositions of H2 -antagonists
GB9705813D0 (en) *	1997-03-20	1997-05-07	Smithkline Beecham Plc	Novel compositions
AR013261A1 (es) *	1997-08-01	2000-12-13	Smithkline Beecham Corp	Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
US7011846B2 (en) *	2001-12-21	2006-03-14	Shire Laboratories, Inc.	Oral capsule formulation with increased physical stability
US7423004B2 (en) *	2003-01-31	2008-09-09	Smithkline Beecham Corporation	Solid dispersion compositions
CN102552917A (zh)	2003-08-13	2012-07-11	比奥孔有限公司	用于治疗剂的微-粒子脂肪酸盐固体剂量制剂
WO2011162756A1 (en)	2010-06-23	2011-12-29	Colgate-Palmolive Company	Therapeutic oral composition
SG190860A1 (en)	2010-12-20	2013-07-31	Colgate Palmolive Co	Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier
EP2654500B1 (de)	2010-12-20	2017-07-19	Colgate-Palmolive Company	In gelatine verkapselte orale pflegezusammensetzung enthaltend einen hydrophilen wirkstoff, einen hydrophoben strukturgebenden stoff und einen ölträger
CN103260585A (zh)	2010-12-20	2013-08-21	高露洁-棕榄公司	包含牙齿封闭活性物的非水性口腔护理组合物
CN109890368B (zh) *	2016-11-01	2021-12-21	强生消费者公司	包含组胺h2受体拮抗剂和抗酸剂的液体口服药物剂型
CN109010303B (zh) *	2017-06-09	2021-05-07	苏州科伦药物研究有限公司	一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) *	2017-07-05	2020-05-07	(주)동구바이오제약	생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물
WO2020051585A1 (en) *	2018-09-07	2020-03-12	R.P. Scherer Technologies, Llc	Solid or semisolid lipid based dosage form stabilization through curing and addition of low hlb surfactant(s)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3374146A (en) *	1966-04-18	1968-03-19	American Cyanamid Co	Sustained release encapsulation
DE2360796B2 (de) *	1973-12-06	1977-06-02	Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München	Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) *	1976-08-04	1980-04-23	Allen & Hanburys Ltd	Aminoalkyl furan derivatives
IT1090703B (it) *	1976-12-03	1985-06-26	Scherer Ltd R P	Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) *	1976-12-17	1984-05-07	中外製薬株式会社	安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) *	1977-11-03	1980-07-30	Hoechst Uk Ltd	Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) *	1979-04-11	1980-10-23	Sumitomo Chem Co Ltd	Diazepam oily drug
EP0040489A1 (de) *	1980-05-17	1981-11-25	FISONS plc	Mischungen, Salze, Packungen und pharmazeutische Zusammensetzungen mit Gehalt an 5-(2-Hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carbonsäure oder einem Derivat derselben und einem H2-Rezeptoren antagonisierenden Antihistamin
IL63968A (en) *	1980-10-01	1985-10-31	Glaxo Group Ltd	Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
CY1306A (en) *	1980-10-01	1985-12-06	Glaxo Group Ltd	Aminoalkyl furan derivative
DE3264782D1 (en) *	1981-10-16	1985-08-22	Sanol Arznei Schwarz Gmbh	Medicinal formulation
JPS58174308A (ja) *	1982-04-06	1983-10-13	Fujimoto Seiyaku Kk	レクタルカプセル坐剤
SE8302689L (sv) *	1982-05-14	1983-11-15	Richter Gedeon Vegyeszet	Farmaceutiska kompositioner innehallande flera aktiva bestandsdelar
DE3237814A1 (de) *	1982-10-12	1984-04-12	Warner-Lambert Co., 07950 Morris Plains, N.J.	Wasserfreie emulsionen und verwendung derselben
JPS60501904A (ja) *	1983-08-01	1985-11-07	ア−ル　ピ−　シエラ−　コ−ポレ−シヨン	徐放方法および製品
GB8903804D0 (en) *	1989-02-20	1989-04-05	Sandoz Ltd	Improvements in or relating to organic compounds
GB8426738D0 (en) *	1984-10-23	1984-11-28	Scras	Pyridine derivatives
GB8516083D0 (en) *	1985-06-25	1985-07-31	Glaxo Group Ltd	Heterocyclic compounds
JPH07549B2 (ja) *	1986-07-03	1995-01-11	ゼリア新薬工業株式会社	軟カプセル充填用組成物
DE3629386A1 (de) *	1986-08-29	1988-03-03	Scherer Gmbh R P	Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) *	1988-05-11	1994-04-12	Glaxo Group Ltd	Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
FR2636532B1 (fr) *	1988-09-20	1993-11-19	Glaxo Group Ltd	Compositions pharmaceutiques

1989
- 1989-02-23 GB GB898904182A patent/GB8904182D0/en active Pending
1990
- 1990-02-21 LU LU87681A patent/LU87681A1/fr unknown
- 1990-02-21 ZW ZW17/90A patent/ZW1790A1/xx unknown
- 1990-02-22 PH PH40086A patent/PH26972A/en unknown
- 1990-02-22 BE BE9000197A patent/BE1003123A3/fr not_active IP Right Cessation
- 1990-02-22 KR KR1019900002250A patent/KR940006271B1/ko not_active Expired - Lifetime
- 1990-02-22 AU AU50073/90A patent/AU629303B2/en not_active Expired
- 1990-02-22 NZ NZ232642A patent/NZ232642A/en unknown
- 1990-02-22 NL NL9000428A patent/NL193267C/nl not_active IP Right Cessation
- 1990-02-22 JP JP2042288A patent/JP2856817B2/ja not_active Expired - Lifetime
- 1990-02-22 CA CA002010692A patent/CA2010692C/en not_active Expired - Lifetime
- 1990-02-22 CH CH569/90A patent/CH680567A5/fr not_active IP Right Cessation
- 1990-02-22 FR FR909002187A patent/FR2643263B1/fr not_active Expired - Lifetime
- 1990-02-22 ZA ZA901348A patent/ZA901348B/xx unknown
- 1990-02-22 DE DE4005650A patent/DE4005650C2/de not_active Expired - Lifetime
- 1990-02-22 AT AT0042190A patent/AT401727B/de not_active IP Right Cessation
- 1990-02-22 IE IE65190A patent/IE63179B1/en not_active IP Right Cessation
- 1990-02-22 DK DK048090A patent/DK170209B1/da not_active IP Right Cessation
- 1990-02-22 IT IT47659A patent/IT1240768B/it active IP Right Grant
- 1990-02-22 IL IL9349090A patent/IL93490A/en not_active IP Right Cessation
- 1990-02-22 GB GB9004016A patent/GB2229094B/en not_active Expired - Lifetime
- 1990-02-22 US US07/482,903 patent/US5028432A/en not_active Expired - Lifetime
- 1990-02-22 SE SE9000625A patent/SE512412C2/sv unknown
- 1990-06-23 SA SA90100287A patent/SA90100287B1/ar unknown
1993
- 1993-08-26 HK HK894/93A patent/HK89493A/xx not_active IP Right Cessation
1994
- 1994-05-06 CY CY173494A patent/CY1734A/en unknown
1995
- 1995-06-29 HU HU95P/P00543P patent/HU211930A9/hu unknown

Also Published As

Publication number	Publication date
IL93490A (en)	1994-07-31
US5028432A (en)	1991-07-02
DE4005650A1 (de)	1990-09-06
GB2229094A (en)	1990-09-19
ZW1790A1 (en)	1991-10-16
KR900012612A (ko)	1990-09-01
IE63179B1 (en)	1995-03-22
NZ232642A (en)	1992-07-28
HK89493A (en)	1993-09-03
AU5007390A (en)	1990-08-30
DK48090D0 (da)	1990-02-22
SE9000625L (sv)	1990-08-24
GB2229094B (en)	1993-01-06
BE1003123A3 (fr)	1991-12-03
SE9000625D0 (sv)	1990-02-22
NL9000428A (nl)	1990-09-17
CH680567A5 (de)	1992-09-30
IT9047659A0 (it)	1990-02-22
KR940006271B1 (ko)	1994-07-14
HU211930A9 (en)	1996-01-29
SE512412C2 (sv)	2000-03-13
DE4005650C2 (de)	1999-03-25
IT1240768B (it)	1993-12-17
DK170209B1 (da)	1995-06-19
FR2643263A1 (fr)	1990-08-24
FR2643263B1 (fr)	1994-09-16
PH26972A (en)	1992-12-28
GB9004016D0 (en)	1990-04-18
AU629303B2 (en)	1992-10-01
NL193267B (nl)	1999-01-04
NL193267C (nl)	1999-05-06
IL93490A0 (en)	1990-11-29
CA2010692C (en)	1995-12-12
ZA901348B (en)	1991-03-27
GB8904182D0 (en)	1989-04-05
DK48090A (da)	1990-08-24
AT401727B (de)	1996-11-25
JP2856817B2 (ja)	1999-02-10
IE900651L (en)	1990-08-23
LU87681A1 (fr)	1991-10-08
JPH03200728A (ja)	1991-09-02
IT9047659A1 (it)	1991-08-22
CA2010692A1 (en)	1990-08-23
SA90100287B1 (ar)	1999-08-15
CY1734A (en)	1994-05-06

Legal Events

Date	Code	Title	Description
2010-11-15	ELA	Expired due to lapse of time

Publication	Publication Date	Title
ATA42190A (de)	1996-04-15	Gelatinekapseln mit einem gehalt an ranitidin (salz)
DK68392A (da)	1992-05-25	Farmaceutisk praeparat indeholdende cefuroximaxetil
KR880011653U (ko)	1988-08-26	의약용 캅셀
DE69029665D1 (de)	1997-02-20	Arzneimittelbehälter enthaltende Kassette
FI883785A0 (fi)	1988-08-16	Kapsel foer farmaceutiskt verksamt inhaleringsaemne i ett laekemedel.
NO831186L (no)	1983-10-03	Fortilsetning for droevtyggere
BR8300391A (pt)	1983-10-25	Ponte de medicao
DK225588D0 (da)	1988-04-26	Farmaceutisk praeparat indeholdende et litiumsalt
FI832197L (fi)	1983-12-25	Farmaceutisk blandning
IT8747991A0 (it)	1987-05-27	Procedimento per la sigillatura di capsule di gelatina dura
DK109887D0 (da)	1987-03-03	Farmaceutisk praeparat indeholdende antistoffer
PT88447A (pt)	1989-07-31	Improved process for preparing gelatine capsules
DK58983D0 (da)	1983-02-11	Farmaceutisk praeparat
FR2638640B1 (fr)	1993-11-26	Solution pharmaceutique
DK140983D0 (da)	1983-03-28	Flaget saltpraeparat
FI912690A7 (fi)	1991-12-07	Pehmeägelatiinikapseli
FI864474L (fi)	1988-05-05	Skruvkapsyloeppnare.
FR2618303B1 (fr)	1991-01-04	Preparation de gelatine presentant un degre bloom eleve a partir de sous-produits de volaille
DE68912947D1 (de)	1994-03-17	Ein lösliches ibopamin-salz enthaltende augenarzneizubereitung.
DE19675047I2 (de)	2003-06-12	Pharmazeutische Zusammensetzung mit einem Gehalt an 4-amino-1-hydroxybutan-1, 1-biphosphonsaeure
FI830617L (fi)	1983-09-11	1,4-dihydropyridin-derivat, deras framstaellning och dessa innehaollande farmaceutiksa produkter
DK164670C (da)	1992-12-14	Pyrrolooe3,2,1-hiaaindol-derivater, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende saadanne forbindelser
DK180883D0 (da)	1983-04-25	Fiskeemballage
FI851052A7 (fi)	1986-09-16	Noskapiinisuola.
NO894984D0 (no)	1989-12-12	Toert mikrobiocid preparat inneholdende et etylen-bis-ditiokarbamatsalt.